Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-08

Clinical Trial Update: CTx-1301 Comparative Bioavailability Study [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for CTx-1301 reporting comparative bioavailability in ADHD, completed Phase 1 and Phase 2 with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CTx-1301

Snippet

Sponsor: Cingulate Therapeutics | Conditions: ADHD | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-04-08